Jean-François Formela

Jean-François Formela is a partner at Atlas Venture which he joined in 1993 to build the US life sciences franchise. He focuses on new advances in biology and drug discovery technologies as well as novel therapeutics.

He is chairman of IFM Therapeutics and serves on the boards of Intellia Therapeutics (NASDAQ: NTLA), F-star, Korro Therapeutics, Kyn Therapeutics, Spero Therapeutics (NASDAQ: SPRO), Translate Bio (NASDAQ: TBIO), which he co-founded, and Triplet Therapeutics, Inc.

Jean-François has been involved in the formation of many biotech companies such as Exelixis, Morphosys, Decode, Translate Bio, Intellia and IFM.

He received his M.D. from Paris University School of Medicine and his M.B.A. from Columbia University.